IMMX · Immix Biopharma, Inc. · Executive Compensation
$12.14
-0.56 (-4.41%)
At close · Sep 11
Going-concern doubt
— flagged Aug 7, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company is unable to entirely fund these efforts with its current financial resources. If adequate funds are unavailable on a timely basis from operations or additional sources of financing, the Company may have to delay, reduce the scope of or eliminate one or more of its research or development programs which may materially and adversely affect its business, financial condition and operations.”View the 10-Q filed Aug 7, 2026
Market Cap
$868.49M
Shares
71.54M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Ilya Rachman | Chief Executive Officer | $1,352,854 |
| Gabriel Morris | Chief Financial Officer | $1,352,854 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Ilya Rachman | Chief Executive Officer | $1,267,158 |
| Gabriel Morris | Chief Financial Officer | $1,267,158 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Ilya Rachman | Chief Executive Officer | $1,129,881 |
| Gabriel Morris | Chief Financial Officer | $1,129,881 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Ilya Rachman | Chief Executive Officer | $2,356,145 |
| Gabriel Morris | Chief Financial Officer | $2,356,145 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Gabriel Morris | Chief Financial Officer | $462,091 |
| Ilya Rachman | Chief Executive Officer | $396,731 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Gabriel Morris | Chief Financial Officer | — |
| Ilya Rachman | Chief Executive Officer | — |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Nancy Chang, Ph.D. | member of the Board | Appointed | 2025-09-08 |